reports
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along wit...
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it is recognizing Mental Illness Awareness Week (MIAW) alongside the national mental health advocacy community including the National Alliance on Mental Illness (NAMI). This year’s theme for MIAW is “Building Community: Supporting Mental Well-being Together,” to highlight the import...
NewtekOne, Inc. to Report Third Quarter 2025 Results and Host a Confer...
NewtekOne, Inc. to Report Third Quarter 2025 Results and Host a Conference Call on Wednesday, October 29, 2025 BOCA RATON, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: NEWT) will report its third quarter 2025 financial results after the market closes on Wednesday, October 29, 2025. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive Officer and Frank DeMaria, Chief Financial Officer of NewtekOne at 4:30 pm ET on Wednesday, October 29, 2025. Please note, to receive a dial-in number for the conference call or to listen to the webc...
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on ...
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3 NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the third quarter of 2025 on Monday, November 3, 2025, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. To participate in the live...
Corcept Therapeutics Inc: 3 directors
Three Directors at Corcept Therapeutics Inc sold after exercising options/sold 65,000 shares at between 84.753USD and 85.081USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades...
Newtek Merchant Solutions Obtains Term Facility and Line of Credit fro...
Newtek Merchant Solutions Obtains Term Facility and Line of Credit from Goldman Sachs Alternatives BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (“NewtekOne” or “Company”) (NASDAQ: NEWT) announced that its wholly owned subsidiary, Newtek Merchant Solutions, LLC (“NMS”), has refinanced its term debt facility and revolving line of credit. Private Credit at Goldman Sachs Alternatives is providing NMS with a $90 million term loan facility and a $5 million line of credit. A portion of the proceeds funded the full repayment of NMS’s approximately $30 million of outstandin...
NewtekOne, Inc. Declares a Quarterly Dividend of $0.19 per Share
NewtekOne, Inc. Declares a Quarterly Dividend of $0.19 per Share BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- (“the Company”) (NASDAQ: NEWT) announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share on the outstanding common stock of NewtekOne. The dividend is payable on October 24, 2025, to shareholders of record as of October 14, 2025. Note Regarding Dividend Payments Amount and timing of dividends, if any, remain subject to the discretion of the Company's Board of Directors. About NewtekOne, Inc. , Your Business Solutions C...
NewtekOne, Inc. Declares Dividend on Series B Preferred Shares
NewtekOne, Inc. Declares Dividend on Series B Preferred Shares BOCA RATON, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- (“the Company”) (NASDAQ: NEWT) has declared a dividend on the Company’s outstanding 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B (the “Preferred Shares”) in the amount of $9.44 per Preferred Share, or $0.2361 per depositary share, which is equivalent to 1/40th of the dividend on the Preferred Shares, payable on October 1, 2025 to holders of record as of September 29, 2025. This initial dividend payment on the Preferred Shares is pro-rated for t...
Green Plains Inc: 1 director
A director at Green Plains Inc sold 30,954 shares at 9.510USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
NewtekOne, Inc. to Participate in the Lytham Partners Fall 2025 Invest...
NewtekOne, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 BOCA RATON, Fla., Sept. 19, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025. Company Webcast The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at or direct...
Axsome Therapeutics Inc: 2 directors
A director at Axsome Therapeutics Inc sold after exercising options/sold 45,783 shares at 114.478USD and the significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
Patriot Financial Partners, L.P. Exchanges NewtekOne, Inc. Convertible...
Patriot Financial Partners, L.P. Exchanges NewtekOne, Inc. Convertible Preferred Shares for Common Equity and Makes $10 Million Incremental Investment BOCA RATON, Fla., Sept. 17, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (“NewtekOne” or the “Company”) (NASDAQ: NEWT) and (“Patriot”) announced today that they have completed a transaction pursuant to which in exchange for all of Patriot’s 20,000 shares of the Company’s convertible preferred stock, Series A, $0.02 par value per share (the “Series A Preferred Stock”) and $10.0 million in cash, the Company issued to Patriot 2,307,692 shares of ...
Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pi...
Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025 Six poster presentations showcase clinical and real-world data in major depressive disorder, Alzheimer’s disease agitation, narcolepsy, and obstructive sleep apnea NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced six presentations across its broad portfolio of innovative neuroscience products and product candidates at Psych Congres...
- Jonathan Moreland
- Dave Nicoski
- Ross LaDuke
PBF PBF ENERGY INC. CLASS A
LEN LENNAR CORPORATION CLASS A
GPRE GREEN PLAINS INC.
GBCI GLACIER BANCORP INC.
FFIC FLUSHING FINANCIAL CORP.
DVN DEVON ENERGY CORPORATION
DECK DECKERS OUTDOOR CORPORATION
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CNO CNO FINANCIAL GROUP INC.
CBU COMMUNITY BANK SYSTEM INC.
BIIB BIOGEN INC.
BC BRUNSWICK CORPORATION
HP HELMERICH & PAYNE INC.
PVH PVH CORP.
TTC TORO COMPANY
HOG HARLEY-DAVIDSON INC.
WGO WINNEBAGO INDUSTRIES INC.
APLS APELLIS PHARMACEUTICALS
PRPL PURPLE INNOVATION
GRWG GROWGENERATION
DCOM DIME COMMUNITY BANCSHARES INC
APA APA CORPORATION
AMR ALPHA METALLURGICAL RESOURCES INC
BBWI BATH & BODY WORKS INC
CIVI CIVITAS RESOURCES INC
BORR BORR DRILLING LTD
MBC_w MASTERBRAND INC
NE NOBLE CORP (NEW)
FTREV FORTREA HOLDINGS INC.
Axsome Therapeutics to Participate in Upcoming Investor Conferences
Axsome Therapeutics to Participate in Upcoming Investor Conferences NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in September: 2025 Wells Fargo Healthcare ConferenceFireside Chat: Wednesday, September 3, 2025, at 3:45 p.m. ET in Boston, MA Cantor Global Healthcare Conference 2025Fireside Chat: Thursday, September 4, 2025, at 1:00 p.m. ET in New York, NY M...
NewtekOne, Inc. Closes Offering of Depositary Shares Each Representing...
NewtekOne, Inc. Closes Offering of Depositary Shares Each Representing 1/40th of an Interest in its Series 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B BOCA RATON, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- On August 20, 2025, (the “Company” or “NewtekOne”) (NASDAQ: NEWT) successfully closed an offering of 2,000,000 depositary shares (the “Depositary Shares”), each representing a 1/40th interest in a share of the Company's 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), with a liquidation preference o...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Speculative Areas Still Leading; Staying Bullish We have discussed since late-July how the S&P 500 (SPX) had not closed below its 20-day MA for three months, but that even when it does, "all we would expect to happen is for a new, less-steep uptrend to form." That is precisely what has happened after the SPX finally lost its 20-day MA (for one whole day) on 8/1/25, only to get back to all-time highs last week. Therefore, we remain near-term bullish since our 4/22/25 Compass, and our intermediat...
INSM INSMED INCORPORATED
GPRE GREEN PLAINS INC.
CYTK CYTOKINETICS INCORPORATED
AXSM AXSOME THERAPEUTICS
ACAD ACADIA PHARMACEUTICALS INC.
REX REX AMERICAN RESOURCES CORPORATION
WVE WAVE LIFE SCIENCES
MRUS MERUS B V
BBIO BRIDGEBIO PHARMA
NVAX NOVAVAX INC.
RNA AVIDITY BIOSCIENCES
IREN IRIS ENERGY LTD
ACLX ARCELLX INC
APLD APPLIED BLOCKCHAIN INC
WGMI COINSHARES BITCOIN MINING ETF
KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
HUT HUT 8 CORP
NewtekOne and Newtek Bank Unveil Real-Time, All-in-One Business Bankin...
NewtekOne and Newtek Bank Unveil Real-Time, All-in-One Business Banking + Merchant Solutions in a Single Online Process BOCA RATON, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (“Newtek”) (NASDAQ: NEWT) and its national bank subsidiary Newtek Bank, N.A. (“Newtek Bank”) have launched a game-changing innovation for independent business owners: a fully integrated onboarding process that delivers both an approved Newtek Bank true Newtek Zero-Fee Business Banking® checking account and a Newtek Merchant Solutions, LLC (“NMS”) merchant payment solution—simultaneously, using a single, ...
Axsome Therapeutics Reports Second Quarter 2025 Financial Results and ...
Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update Total 2Q 2025 net product revenue of $150.0 million, representing growth of 72% year-over-year and 24% sequentially AUVELITY® 2Q 2025 net product sales of $119.6 million, representing growth of 84% year-over-year and 24% sequentially SUNOSI® 2Q 2025 net product revenue of $30.0 million, representing growth of 35% year-over-year and 19% sequentially SYMBRAVO® launched June 10th, with 2Q 2025 net product sales of $0.4 million AUVELITY® market access expanded by 28 million...
NewtekOne, Inc. Upsizes Additional Warehouse Facility to Support Growt...
NewtekOne, Inc. Upsizes Additional Warehouse Facility to Support Growth of ALP Business BOCA RATON, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- (“NewtekOne”) (NASDAQ: NEWT) announced that its consolidated subsidiary, Newtek ALP Holdings, amended its revolving credit facility with Capital One, N.A. (“Capital One”), which is employed to fund the origination of Alternative Loan Program (“ALP”) loans before they are placed into securitizations. The amendment provides for, among other things, a facility increase from $60 million to $100 million and a maturity extension of two years. The amended a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.